Professional Documents
Culture Documents
PT Imeco Inter Sarana BVD 05 - 08 - 2022 06 - 16
PT Imeco Inter Sarana BVD 05 - 08 - 2022 06 - 16
INTER SARANA, PT
JAKARTA SELATAN, Indonesia
Active Private
BvD ID: ID13706P Orbis ID: 051087192 This company is the Global Ultimate Owner of the corporate group
Free chapter
BELTWAY OFFICE PARK BUILDING C, 7TH FLOOR, JL. Legal form: Limited liability company - PT
AMPERA RAYA 9-10 Activity: Corporate, Wholesale
12550 JAKARTA SELATAN Date of incorporation: 03/05/1972
Indonesia
Activity
BvD major sector:
Wholesale & retail trade
US SIC Core code:
Machinery, equipment, and supplies wholesale dealing in (508)
NACE Rev. 2 Core code:
Wholesale of other machinery and equipment (4669)
NAICS 2012 Core code:
Machinery, Equipment, and Supplies Merchant Wholesalers (4238)
BELTWAY OFFICE PARK BUILDING C, 7TH FLOOR, JL. Legal form: Limited liability company - PT
AMPERA RAYA 9-10 Activity: Corporate, Wholesale
12550 JAKARTA SELATAN Date of incorporation: 03/05/1972
Indonesia
Operating revenue (Turnover) P/L [=Net Income]
Ownership PEPs and sanctions
Financial profile
No financial information available
Directors News stories since last year
+ 1 more
Low
risk
2 0 BB
Financial risk review summary
Financial
High Quantitative Qualitative
risk
Low
risk
26/07/22
Contact information
BELTWAY OFFICE PARK BUILDING C, 7TH FLOOR, JL. ISO territory code ID
AMPERA RAYA 9-10
12550 JAKARTA SELATAN Province Jakarta
Indonesia
Type of entity: Corporate
BvD sector: Wholesale
NACE Rev. 2 main section: G - Wholesale and retail trade; repair of motor vehicles and motorcycles
Trade description
Oilfield and offshore equipment
BvD ID number ID13706P
Orbis ID number 051087192
TIN (VAT/Tax number) 01.309.910.6-091.000
TIN (TIN) 01.309.910.6-091.000
DIS number (IP identification) 13706
Active PEPs and sanctions
Indonesia
General information
GDP per head at constant $ rate (USD) n.a. n.a. 3,757 3,877
Forecast period
Source: Moody's Analytics
Additional information
GDP per head at constant $ World Development Indicators: GDP per capita; (constant 2015 USD)
rate (USD)
Budget balance (% of GDP) Government Finance Statistics: General government [S.13] - Revenue cash flows;
(IDR)|Government Finance Statistics: General government [S.13] - Expense cash
flows; (IDR)|International Financial Statistics: National accounts - Gross Domestic
Product - Nominal; (IDR)
Unemployment (% of labour Labor Force Survey: Population and Type of Activity - Unemployment Rate; (%;
force) NSA)
Source: Statistics Indonesia of the Republic of Indonesia
The company discloses no figure for ‘Operating revenue (Turnover)’ in its last available accounts. Consequently, the standard
peer group based on this variable is undefined.
Peer group definition
Closest 10 international companies according to the Operating revenue (Turnover) of the subject company for the last
available year amongst the standard peer group.
The standard peer group is based on NACE Rev. 2 industry classification for corporate, specialisation for banks and company
class for insurance companies: 0 - .
Financial strength summary
Low
risk
2 0 BB
5 1
2 - Above average
risk
on 01/05/2022
Current Index (12/04/2022): 18
Peak Index (26/10/2021): 25
Repartition of risk: 0% environmental
AAA D 0% social
0% governance
BB - Moderate
Industry: Utilities
on 12/04/2022
Evolution over time
High risk D 100
C 90
CC 80
CCC 70
B 60
BB 50
BBB 40
A 30
AA 20
AAA 10
0
Low risk
A J A O D F A J A O D F A J A O D F A
Rating Index
2019 2020 2021 2022
Legend
Rating
Index
The RepRisk Index (RRI) captures the company-specific reputational risk related to ESG issues, while the RepRisk
Rating (RRR) is a comprehensive, yet simple rating of a company’s risk exposure related to ESG issues. The RRR
combines a company’s own ESG risk exposure with the ESG risk exposure of the countries and sectors in which the
company has been exposed to risks.
Evolution over time (Tabular view)
Date Rating Index
03/2022 BB 19
02/2022 BB 20
01/2022 BB 22
11/2021 BB 25
10/2021 BB 0
09/2021 BB 0
08/2021 BB 0
07/2021 BB 0
06/2021 BB 0
05/2021 BB 0
04/2021 BB 0
03/2021 BB 0
02/2021 BB 0
01/2021 BB 0
12/2020 BB 0
11/2020 BB 0
10/2020 BB 0
09/2020 BB 0
08/2020 BB 0
07/2020 BB 0
06/2020 BB 0
05/2020 BB 0
04/2020 BB 0
03/2020 BB 0
02/2020 BB 0
01/2020 BB 0
12/2019 BB 0
11/2019 BB 0
10/2019 BB 0
09/2019 BB 0
08/2019 BB 0
07/2019 BB 0
06/2019 BB 0
04/2019 BB 0
Financial risk review summary
Financial
High Quantitative Qualitative
risk
Low
risk
26/07/22
Credit limit: 241,265 $
Based on geographical and sector statistics.
Evolution over time
High risk E
Low risk A
Legend
Industry score
Qualitative score A B C C C
Industry score C C C C C
Observations
2020 The company's score is factoring also a country risk component (measured
through Credit Default Swaps spread).
2019 The company's score is factoring also a country risk component (measured
through Credit Default Swaps spread).
2018 The company's score is factoring also a country risk component (measured
through Credit Default Swaps spread).
2016 The company's score is factoring also a country risk component (measured
through Credit Default Swaps spread).
Boards of directors
MR TANU WIJAYA
DI
President Director
A. L. MULYONO
DI
Director
MR SARWI NOTOATMODJO
DI
Director
Source
Filters
Formal sources
Bodies & departments
Banker 1
BANK MANDIRI TBK., PT (PERSERO)
DI
Banker
Legend
There are names that are the same, or similar to, a risk relevant name
Source
DI:Dataindo Inti Swakarsa
Graph : Shareholders
This company does not have shareholders.
Ultimate Owner definition
The path from the company to its Ultimate Owner is minimum 25.01%
I consider a company the Ultimate Owner if there are no identified shareholders or if the shareholder percentage is not
known.
The map represents the geographic location of the companies in the corporate group
All 3 companies in the corporate group are represented
Legend
Number of entities by country Country of both the company and the GUO
■ More than 1
■ Less than 1
Ultimate Owner definition
The path from the company to its Ultimate Owner is minimum 25.01%
I consider a company the Ultimate Owner if there are no identified shareholders or if the shareholder percentage is not
known.
Global Ultimate Owner
Ultimately owned subsidiaries
Name
Date
Global Ultimate Owner
Ultimately owned subsidiaries
Legend
MO = Majority owned
Ultimate Owner definition
The path from the company to its Ultimate Owner is minimum 25.01%
I consider a company the Ultimate Owner if there are no identified shareholders or if the shareholder percentage is not
known.
There is no current shareholder with more than 10.00% for this company.
Beneficial Owner definition
The minimum percentage of ownership at first level is 10.00%, the minimum percentage at further levels is 10.00%.
I also consider any individual at the top of a path who has an unknown percentage of ownership (% such as ‘>x%’ are
considered unknown)
I also consider any individual at the top of a path who has a percentage of minimum 10.00% (with the requested 10.00% at
all other levels).
Beneficial Owners from register are not subject to the defined thresholds.
BvD independence indicator
B C U - Unknown independence status
Has no identified shareholders or any with a known % of ownership
A D
Ultimate Owner definition
The path from the company to its Ultimate Owner is minimum 25.01%
I consider a company the Ultimate Owner if there are no identified shareholders or if the shareholder percentage is not
known.
Legend
C = Corporate
MO = Majority owned
Company profiles
Filters:
Moody's Investors Service, Moody’s Analytics Capital Markets, MarketLine, Morningstar, GlobalData
Industry profiles
Global Biotechnology 26/06/2020
Global Biotechnology 17/12/2019
Global Biotechnology 20/06/2018
Global Biotechnology 03/10/2017
Global Biotechnology 22/11/2016
Global Biotechnology 18/01/2016
Global Biotechnology 01/01/2015
Global Biotechnology 01/07/2013
Global Biotechnology 01/07/2012
Global Biotechnology 01/08/2011
Global Biotechnology 01/05/2010
Global Biotechnology 01/07/2009
Global Biotechnology 01/08/2008
Global Biotechnology 01/08/2007
Global Biotechnology 01/09/2006
Global Biotechnology 01/10/2005
Global Biotechnology 01/05/2005
Global Biotechnology 01/12/2003
Biotechnology in Asia-Pacific 26/06/2020
Biotechnology in Asia-Pacific 17/12/2019
Biotechnology in Asia-Pacific 20/06/2018
Biotechnology in Asia-Pacific 03/10/2017
Biotechnology in Asia-Pacific 22/11/2016
Biotechnology in Asia-Pacific 18/01/2016
Biotechnology in Asia-Pacific 01/01/2015
Biotechnology in Asia-Pacific 01/07/2013
Biotechnology in Asia-Pacific 01/07/2012
Biotechnology in Asia-Pacific 01/08/2011
Biotechnology in Asia-Pacific 01/05/2010
Biotechnology in Asia-Pacific 01/07/2009
Biotechnology in Asia-Pacific 01/08/2008
Biotechnology in Asia-Pacific 01/08/2007
Biotechnology in Asia-Pacific 01/09/2006
Biotechnology in Asia-Pacific 01/10/2005
Biotechnology in Asia-Pacific 01/11/2004
Biotechnology in Asia-Pacific 01/12/2003
Global Generics 18/08/2020
Global Generics 21/11/2019
Global Generics 21/08/2018
Global Generics 20/01/2017
Global Generics 04/01/2016
Global Generics 01/12/2014
Global Generics 01/08/2013
Global Generics 01/06/2012
Global Generics 01/08/2011
Global Generics 01/07/2010
Global Generics 01/05/2010
Global Generics 01/07/2009
Global Generics 01/08/2008
Global Generics 01/08/2007
Global Generics 01/08/2006
Global Generics 01/08/2005
Global Generics 01/08/2004
Global Generics 01/12/2003
Generics in Indonesia 18/08/2020
Generics in Indonesia 21/11/2019
Generics in Indonesia 21/08/2018
Generics in Indonesia 27/10/2017
Generics in Indonesia 20/01/2017
Generics in Indonesia 04/01/2016
Generics in Asia-Pacific 18/08/2020
Generics in Asia-Pacific 21/08/2018
Generics in Asia-Pacific 27/10/2017
Generics in Asia-Pacific 20/01/2017
Generics in Asia-Pacific 04/01/2016
Generics in Asia-Pacific 01/12/2014
Generics in Asia-Pacific 01/08/2013
Generics in Asia-Pacific 01/06/2012
Generics in Asia-Pacific 01/08/2011
Generics in Asia-Pacific 01/07/2010
Generics in Asia-Pacific 01/05/2010
Generics in Asia-Pacific 01/07/2009
Generics in Asia-Pacific 01/08/2008
Generics in Asia-Pacific 01/08/2007
Generics in Asia-Pacific 01/08/2006
Generics in Asia-Pacific 01/08/2005
Generics in Asia-Pacific 01/08/2004
Generics in Asia-Pacific 01/04/2004
Appendix – Omitted chapters
The chapters listed below have been omitted because they have no data for this company, or the data cannot be represented
in the PDF
Accounting information
Legal events
Detailed format
Graph - Value over time
Graph - Indices of several values over time
Cash flow statement
Segment data - Business lines
Segment data - Geographic segments
Graph - company ratings over time
Falcon counterparty risk score by Zanders
Financial stability score by CRIF Decision Solutions Ltd
Predictive indicators by Vadis
Global score by WVB
Compass score merchant risk by G2
Environmental score by Trucost
MORE credit risk score by modeFinance
Reactive MORE credit risk score by modeFinance
National scores
Stock profile
Annual stock data
Annual stock valuation
Pricing series
Beta and price volatility
Earnings estimates
Credit default swaps
Previous directors & managers
Current shareholders
Shareholders history
Royalties agreements
Company and market news
Mergers & acquisitions
Crossborder investments
Liquidity events & potential beneficiaries
Local registry documents
aRMadillo
Global reports
EOL SEC filings